Primary Combined Hepatocellular-Cholangiocarcinoma: A Case of Underdiagnosed Primary Liver Cancer

被引：3

作者：

Ayas, Mohamad F. ^{[1
]}

Affas, Saif ^{[1
]}

Ayas, Zayd ^{[2
]}

Chand, Momal ^{[3
]}

Hadid, Tarik ^{[4
]}

机构：

[1] Ascension St John Hosp, Internal Med, Detroit, MI 48236 USA

[2] Univ Texas Austin, Coll Nat Sci, Basic Sci, Austin, TX 78712 USA

[3] Ascension St John Hosp, Pathol, Detroit, MI USA

[4] Ascension St John Hosp, Oncol, Detroit, MI USA

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2021年 / 13卷 / 09期

关键词：

hepatocellular carcinoma (hcc); cholangiocarcinoma; combined hepatocellular-cholangiocarcinoma; trans-arterial radioembolization; liver tumor; CARCINOMA; TRANSPLANTATION; FEATURES; OUTCOMES;

D O I：

10.7759/cureus.18224

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Combined hepatocellular-cholangiocarcinoma (CHC) is a rare primary tumor of the liver. Histologically, it comprises components of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) but is associated with a worse prognosis. International guidelines regarding its management are scarce, with surgical management (major hepatectomy) being the treatment of choice. In this report, we present a challenging case of a 73-year-old male with primary CHC who was not a surgical candidate but underwent hepatic artery radioembolization instead.

引用

页数：6

共 50 条

[21] Combined hepatocellular-cholangiocarcinoma in a cow
Honda, Hidetsugu
Kiku, Yoshio
Mikami, Osamu
Ishikawa, Yoshiharu
Kadota, Koichi
JOURNAL OF VETERINARY MEDICAL SCIENCE, 2020, 82 (01) : 84 - 88
[22] Diagnosis, clinical characteristics, and treatment of combined hepatocellular-cholangiocarcinoma
Terashima, Takeshi
Harada, Kenichi
Yamashita, Taro
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2025, 55 (04) : 327 - 333
[23] Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification
Yen, Chih-Chieh
Yen, Chia-Jui
Shan, Yan-Shen
Lin, Yih-Jyh
Liu, I-Ting
Huang, Hsuan-Yi
Yeh, Matthew M.
Chan, Shih-Huang
Tsai, Hung-Wen
HISTOPATHOLOGY, 2021, 79 (04) : 556 - 572
[24] Case Report: Long lasting response with TKI for combined hepatocellular-cholangiocarcinoma
Deiana, Chiara
Palloni, Andrea
Mosca, Mirta
Vasuri, Francesco
Chillotti, Stefano
Tavolari, Simona
de Biase, Dario
Frega, Giorgio
Giovannetti, Elisa
Brandi, Giovanni
FRONTIERS IN ONCOLOGY, 2025, 15
[25] Tumor burden score is superior to primary liver cancer stages in predicting prognosis for patients with combined hepatocellular-cholangiocarcinoma after surgery: A multi-center study
Jiang, Chuang
Qin, Fangying
Yan, Jiaxin
Zou, Jing
Wang, Haiqing
Zhang, Hui
Feng, Xielin
Hou, Guimin
EJSO, 2024, 50 (11):
[26] A Case Review on Combined Hepatocellular Cholangiocarcinoma
Kondo, Reiichiro
Akiba, Jun
Yano, Hirohisa
AJSP-REVIEWS AND REPORTS, 2022, 27 (06) : 248 - 253
[27] Genetic classification of combined hepatocellular-cholangiocarcinoma
Fujii, H
Zhu, XG
Matsumoto, T
Inagaki, M
Tokusashi, Y
Miyokawa, N
Fukusato, T
Uekusa, T
Takagaki, T
Kadowaki, N
Shirai, T
HUMAN PATHOLOGY, 2000, 31 (09) : 1011 - 1017
[28] Radiofrequency ablation versus liver resection and liver transplantation for small combined hepatocellular-cholangiocarcinoma stratified by tumor size
Peng, Shuai
Dong, Song-Chen
Bai, Dou-Sheng
Zhang, Chi
Jin, Sheng-Jie
Jiang, Guo-Qing
LANGENBECKS ARCHIVES OF SURGERY, 2023, 408 (01)
[29] Living donor liver transplantation for combined hepatocellular-cholangiocarcinoma: A case series of four patients
Ito, Takashi
Ishii, Takamichi
Sumiyoshi, Shinji
Ogiso, Satoshi
Fukumitsu, Ken
Yagi, Shintaro
Seo, Satoru
Hata, Koichiro
Taura, Kojiro
Uemoto, Shinji
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2020, 74 : 46 - 52
[30] Combined hepatocellular-cholangiocarcinoma: A clinicopathological study
Ng, IOL
Shek, TWH
Nicholls, J
Ma, LT
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 (01) : 34 - 40

← 1 2 3 4 5 →